Orchid Gets USFDA Nod For ‘Cefpodoxime’

Orchid_logoIndia's Orchid Chemicals & Pharmaceuticals Ltd has announced that it has received approv

Over 1, 100 feared dead as Cyclone Sidr hits Bangladesh

Dhaka, Nov 17 (ANI): BangladeshOver 1, 100 were feared dead and thousands others injured i

AICC session begins, Indo-US nuke deal and Nandigram likely to be discussed

New Delhi, Nov 17 (ANI): All India Congress CommitteeThe seventeenth All India Congr

Sony Ericsson Unveils ‘W910i’ Mobile Phone In Indian Market

w910-10Sony Ericsson India has made announcement of the launching of its latest slim slider mobile phon

GSLV Launcher - What A Achievement By ISRO!

GSLV_launcherBangalore: ISRO researchers have achieved success in reaching a new galaxy

KEC Int. Receives Order Worth Rs. 637 Crores

KEC_logoKEC International Ltd has bagged two major project from Abu Dhabi and Algeria, valued at Rs 391

Pages

News in Focus

L&T Finance Share Price Target at Rs 370: ICICI Securities

ICICI Securities has upgraded L&T Finance (LTF) to a BUY rating from ADD, setting a fresh 12-month target price of Rs 370, implying roughly 15% upside from the current market price of Rs 321.

Suzlon Energy Share Price Target at Rs 65: Deven Choksey Research

Deven Choksey Research has reiterated a BUY rating on Suzlon Energy Ltd ahead of its Q1FY27 results, setting a revised target price of Rs 65 — a 22% upside from the current market price of Rs 53.

Buying Used Cars in Dubai? OneClickDrive, DubiCars, CarSwitch and dubizzle Emerge as Top Platforms

Dubai’s used-car market can be a bargain hunter’s dream and a compliance minefield at the same time.

Anand Rathi Recommends BUY on Indian Bank With Share Price Target at Rs 1,098

Indian Bank has kicked off FY27 on a strong footing, prompting Anand Rathi to reaffirm its BUY recommendation with a 12-month target price of Rs 1,098.

Bajaj Consumer Care Share Price Target at Rs 760: ICICI Securities Issues Bullish Outlook

Bajaj Consumer Care has received a reaffirmed BUY recommendation from ICICI Securities, which has increased its 12-month target price to Rs 760 from Rs 600, implying an upside potential of around 1